Sleep Diagnostics assests sold to Embla Systems

NewsGuard 100/100 Score
Sep 21 2009

Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it had completed the previously announced sale of its Sleep Diagnostics assets to Embla Systems. Financial terms of the transaction were not disclosed.

The sale of the Sleep Diagnostics product line, which includes several products sold under the Sandman™ brand, was made following a thorough review and evaluation of a number of strategic alternatives. The decision is consistent with Covidien’s strategy to streamline its portfolio and reallocate resources to its faster-growing, higher-margin businesses, where the Company has or can develop a global competitive advantage.

http://www.covidien.com/covidien/pageBuilder.aspx?page=Home:Home&topicID=161206

Posted in:

Tags: , ,

Comments (0)

Suggested Reading

Short and long sleep durations associated with higher diabetes incidence, study finds
Brain cell connections weakened during first half of sleep, study reveals
Study links endocrine-disrupting chemical exposure to poorer sleep and vitamin D deficiency
Study finds microdosing LSD leads to longer sleep: Insights from a controlled trial
New review explores the key gender differences in sleep, circadian rhythms and metabolism
Research identifies a unique protein fingerprint linked to very short sleep and increased diabetes risk
New sleep-enhancing nutraceutical blend falls short in clinical trial
Excessive internet use plus lack of sleep, exercise linked to teen truancy and school absence

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Sleep strategies may boost ultramarathon performance, study finds